Three per cent dextran-60 as a plasma substitute in blood component therapy. II. Comparative studies on pre- and postoperative blood volume.
Microaggregate-poor erythrocyte concentrate with 3% dextran-60 as a plasma substitute was compared with microaggregate-poor whole blood for replacement of intra-operative blood loss. Their blood volume-conserving effects were studied by sequential blood volume determination with radioactive technetium (99mTc) in 19 patients undergoing total hip arthroplasty. Pre-operatively there was no difference in blood volume between the groups. Immediately after surgery and on the 2nd postoperative day there was no difference in total blood volume. Blood component therapy with 3% dextran as a plasma substitute is an efficient principle for intra-operative blood loss replacement at hip operations.
U
U
Schött
T
T
Thorén
U
U
Sjöstrand
O
O
Berséus
B
B
Söderholm
D000368:Aged; D001798:Blood Proteins / Q000378:metabolism; D001810:Blood Volume; D003911:Dextrans / Q000627:therapeutic use*; D017707:Erythrocyte Transfusion; D004911:Erythrocyte Volume; D005260:Female; D006400:Hematocrit; D006470:Hemorrhage / Q000628:therapy*; D006622:Hip Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010952:Plasma Substitutes / Q000627:therapeutic use*; D011184:Postoperative Period; D012709:Serum Albumin / Q000378:metabolism; D013514:Surgical Procedures, Operative / Q000009:adverse effects*; D013667:Technetium; D013997:Time Factors
D001798:Blood Proteins; D003911:Dextrans; D010952:Plasma Substitutes; D012709:Serum Albumin; D013667:Technetium